Xiao Fang Pharma released its semi-annual performance, with a net profit attributable to the parent company of 121 million yuan, a year-on-year increase of 1.69%

Zhitong
2025.08.25 11:45
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, Xiao Fang Pharma disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 270 million yuan, a year-on-year increase of 3.06%; net profit attributable to shareholders was 121 million yuan, a year-on-year increase of 1.69%; net profit excluding non-recurring items was 121 million yuan, a year-on-year increase of 2.04%; basic earnings per share were 0.75 yuan. The company plans to distribute a cash dividend of 7.00 yuan (including tax) for every 10 shares to all shareholders

According to the Zhitong Finance APP, Xiao Fang Pharma (603207.SH) disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 270 million yuan, a year-on-year increase of 3.06%; net profit attributable to shareholders was 121 million yuan, a year-on-year increase of 1.69%; net profit excluding non-recurring items was 121 million yuan, a year-on-year increase of 2.04%; basic earnings per share were 0.75 yuan. The company plans to distribute a cash dividend of 7.00 yuan (including tax) for every 10 shares to all shareholders

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.